Prostatis Group’s iShares MSCI EAFE Min Vol Factor ETF EFAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-21,431
Closed -$21.4K 133
2023
Q2
$21.4K Buy
+21,431
New +$1.48M 0.01% 223
2022
Q2
Sell
-41,741
Closed -$3.01M 57
2022
Q1
$3.01M Buy
41,741
+1
+0% +$73 2.41% 16
2021
Q4
$3.2M Buy
41,740
+1,926
+5% +$147K 1.97% 19
2021
Q3
$3M Buy
39,814
+1,525
+4% +$118K 1.79% 18
2021
Q2
$2.89M Sell
38,289
-29,462
-43% -$2.22M 1.98% 13
2021
Q1
$4.95M Buy
67,751
+9,801
+17% +$719K 3.88% 7
2020
Q4
$4.25M Buy
57,950
+21,428
+59% +$1.51M 3.56% 7
2020
Q3
$2.49M Buy
36,522
+13,480
+59% +$918K 2.36% 12
2020
Q2
$1.52M Buy
+23,042
New +$1.5M 3.06% 8

Other funds holding EFAV

Prostatis Group's EFAV Position: Q3 2023 in Review

Prostatis Group sold out of iShares MSCI EAFE Min Vol Factor ETF (EFAV) in Q3 2023, closing a stake of 21,431 shares — an estimated $21.4K sold.

Prostatis Group first reported a position in EFAV in Q2 2020 and held it in 9 quarters. The position peaked at $4.95M in Q1 2021. 468 funds tracked by Wall St. Rank hold EFAV as of Q3 2023.

  • Prostatis Group reported no remaining iShares MSCI EAFE Min Vol Factor ETF position as of Q3 2023 after selling out during the quarter.
  • Prostatis Group sold 21,431 iShares MSCI EAFE Min Vol Factor ETF shares in Q3 2023, an estimated $21.4K.
  • Prostatis Group first reported a position in iShares MSCI EAFE Min Vol Factor ETF in Q2 2020 and held it in 9 quarters.
  • Prostatis Group's iShares MSCI EAFE Min Vol Factor ETF position peaked at $4.95M in Q1 2021.
  • 468 funds tracked by Wall St. Rank held iShares MSCI EAFE Min Vol Factor ETF as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.